The arithmetic of defence expansion rarely comes cheap, and investors in Czechoslovak Group got a sharp reminder of that on Friday. Shares in the Prague-based arms manufacturer slid 6.83 percent to close at €18.11, erasing a chunk of the hefty gains accumulated over the preceding month — a period that still leaves the stock up 32.6 percent over 30 days.
The pullback came hot on the heels of half-year results that, on the surface, looked anything but disappointing. Revenue climbed 17.2 percent to €3.251 billion, while operating EBIT advanced 12.7 percent to €784 million, translating into a margin of 24.1 percent — comfortably inside management’s guided range. The full-year outlook was reaffirmed at €7.4 billion to €7.6 billion in sales with an EBIT margin between 24 and 25 percent.
The Working Capital Squeeze
The problem lay further down the income statement, in a line item that has become the defining tension of CSG’s current growth phase. An operating cash flow of minus €411 million — the product of a €1.2 billion build-up in working capital — spooked investors who had bid the stock up sharply in recent weeks. The company attributes the cash drain to strategic stockpiling of components for medium- and long-range ammunition, a deliberate bet on securing supply chains ahead of production ramp-ups.
That bet has consequences for the balance sheet. Net debt rose to €2.914 billion, pushing the leverage ratio to 1.6 times trailing twelve-month operating EBITDA — well above the sub-1.3 level targeted for year-end. Management, however, insists the pinch is temporary, pointing to an expected release of €1.5 billion in working capital during the second half, with the fourth quarter doing the heavy lifting. The full-year target of keeping net working capital below 20 percent of revenue remains intact.
Managing industrial-scale operations brings its own set of risks, and documenting them properly is a legal obligation that many businesses get wrong. A free toolkit with 41 ready-to-use templates and checklists helps you stay on top of workplace safety requirements without the administrative headache. Download the free Risk Assessment Toolkit
Land Systems Doubles Down
Beneath the headline numbers, the strategic pivot within CSG’s portfolio is unmistakable. Land Systems — the division producing everything from artillery to armoured vehicles — doubled its revenue year-on-year to €445 million and now accounts for 46 percent of the division’s €17 billion order backlog. The group’s total backlog, including pipeline, expanded from €44 billion to €46 billion.
Just as telling is the shifting geography of demand. Ukraine’s share of CSG’s order book has fallen from 27 percent to 17 percent, while NATO markets have grown in relative importance — a deliberate diversification away from what had become a dominant single customer. The company’s own production targets underscore the scale of the ramp: large-calibre ammunition output is slated to rise from 550,000 rounds in 2025 to roughly 850,000 rounds by the end of this year, with 60 percent of long-range munitions to be manufactured in-house by end-2026. The Karpat battle tank is scheduled to roll off production lines from Q1 2027, with full vertical integration targeted by the end of that year.
Should investors sell immediately? Or is it worth buying CSG?
Building Out the Industrial Base
The half-year report was accompanied by a flurry of corporate activity that extends well beyond the numbers. On 4 August, CSG’s German subsidiary CSG Energetic Materials Germany completed the acquisition of a 57-hectare industrial site in Gnaschwitz near Bautzen, Saxony, from MAXAM. The company plans to invest more than €100 million in a first expansion phase, establishing production capacity for nitroglycerin and nitroglycerin-based products, as well as ammunition and ammunition components. Up to 125 new jobs are expected to be created.
The following day brought news of a strategic stake in North Vector Dynamics, a Canadian developer of air defence technologies, precision-guided missiles, counter-drone systems and next-generation hypersonics. The investment amount remains undisclosed, though the Canadian firm’s valuation now exceeds US$90 million.
New Leadership, New Products
CSG has also been strengthening its executive bench. Ben Hudson, an Australian defence industry veteran with more than three decades of experience, took up the role of vice-chairman of the board on 1 August. Hudson — who joined the group in June as CEO of CSG Land Systems and group chief technology officer — previously led Hanwha Europe, UK and Australia, served as group CTO at BAE Systems, and headed Rheinmetall’s vehicle systems division.
On the product front, the Eurosatory defence exhibition in late July provided a platform for several unveilings. CSG showcased the Tadeas armoured vehicle in a new 4×4 command variant, complementing the existing 6×6 configuration and designed for command, communications and reconnaissance missions. The group also formally presented Trident, a multi-layered air defence system. Meanwhile, subsidiary AviaNera Technologies signed a cooperation agreement with Ukrainian firm Ukrainian Armor covering the development and delivery of propulsion systems for guided missiles and unmanned platforms — with the possibility of a joint venture and expanded manufacturing, including technology localisation in Ukraine.
Working with hazardous substances — whether in manufacturing, chemicals or energy — carries strict legal duties you can’t afford to overlook. A free COSHH toolkit with 43 customisable templates and checklists helps you meet your risk assessment obligations and keep your workforce protected. Get the free COSHH Toolkit
For investors, the picture that emerges is one of a company executing aggressively on multiple fronts — geographic diversification, vertical integration and product expansion — while asking the market to accept a temporary deterioration in cash conversion as the price of that ambition. Whether the promised second-half release of working capital materialises will likely determine whether Friday’s dip proves a blip or the start of a reassessment.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from August 10 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 10.
CSG: Buy or sell? Read more here...
